Aethlon Medical (AEMD) Receives Daily Coverage Optimism Rating of 0.56
Headlines about Aethlon Medical (OTCMKTS:AEMD) have trended very positive on Friday, Alpha One Sentiment Analysis reports. Alpha One, a division of Accern, identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Alpha One ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aethlon Medical earned a media sentiment score of 0.56 on Alpha One’s scale. Alpha One also assigned press coverage about the medical equipment provider an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an effect on the stock’s share price in the next few days.
Shares of Aethlon Medical (OTCMKTS:AEMD) traded up 0.9902% on Friday, reaching $2.0501. 3,881 shares of the company’s stock traded hands. The stock’s 50-day moving average price is $2.36 and its 200-day moving average price is $3.73. Aethlon Medical has a 52 week low of $2.03 and a 52 week high of $9.09. The stock’s market capitalization is $16.32 million.
About Aethlon Medical
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Stock Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related stocks with our FREE daily email newsletter.